ABILIFY MAINTENA KIT Drug Profile, 2020

$499.00

ABILIFY MAINTENA KIT Drug Profile, 2020

This report focuses on ABILIFY MAINTENA KIT and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • District Court patent litigation
  • Patent Trial and Appeal Board (PTAB) patent cases
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources
SKU: 202971 Category:

Description

Copyright © DrugPatentWatch. Originally published at ABILIFY MAINTENA KIT Drug Profile, 2020

ABILIFY MAINTENA KIT Drug Profile, 2020

This report focuses on ABILIFY MAINTENA KIT and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • District Court patent litigation
  • Patent Trial and Appeal Board (PTAB) patent cases
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources

Contents

  • Profile for ABILIFY MAINTENA KIT
  • US Patents
  • US Regulatory Exclusivity
  • Expired US Patents
  • US District Court Litigation
  • US Patent Trial and Appeal Board Cases
  • International (exUS) Patents
  • Supplementary Protection Certificates
  • Clinical Trials
  • Drug Prices – Best Wholesale Price
  • Finished Product Suppliers
  • Bulk API Sources

    Make Better Decisions with DrugPatentWatch

    Try a trial or schedule a demo

    Copyright © DrugPatentWatch. Originally published at ABILIFY MAINTENA KIT Drug Profile, 2020